Is TScan Therapeutics, Inc. (TCRX) a Buy, Sell, or Hold?
NASDAQ : TCRX
TScan Therapeutics, Inc. — Institutional Ownership
$0.773 USD
$0.0 (-0.49%)
- Volume
- 523.99K
- Average Volume
- 829.65K
- Market Capitalization
- $47.21M
- P/E Ratio
- -0.85
- Dividend Yield
- 0.00%
- Price Target
- $7.50
- Year High
- $2.57
- Year Low
- $0.72
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $3.23
Institutional Ownership Summary
Institutional Ownership %
%
Investors Holding
change: 0.0 | last:
Increased Positions
change: 0.0 | last:
Reduced Positions
change: 0.0 | last:
New Positions
change: 0.0 | last:
Sold Positions
change: 0.0 | last:
Total Calls
-
Total Puts
-
Put-Call Ratio
change: 0.0 | last:
Total Invested
-
Beneficial Ownership Filings
| Filing Date | Reporting Person | Amount Beneficially Owned | % of Class |
|---|---|---|---|
| 2026-05-15 | BIOTECHNOLOGY VALUE FUND L P | 3.01M | 5.40% |
| 2025-08-14 | Lynx1 Capital Management LP | 7.86M | 15.00% |
| 2025-08-12 | Adage Capital Management, L.P. | 1.35M | 2.52% |
| 2025-07-16 | BlackRock, Inc. | 958.37K | 1.80% |
| 2025-05-15 | EcoR1 Capital, LLC | 662.83K | 1.30% |
| 2025-05-15 | BIOTECHNOLOGY VALUE FUND L P | 3.35M | 6.40% |
| 2025-04-24 | BlackRock, Inc. | 2.83M | 5.40% |
| 2025-02-14 | Lynx1 Capital Management LP | 5.36M | 10.90% |
| 2025-02-14 | K2 HealthVentures Equity Trust LLC | 3.6M | 6.90% |
| 2025-02-12 | Adage Capital Management, L.P. | 3.5M | 7.13% |
| 2024-11-08 | (1) BlackRock, Inc. | 4.63M | 9.50% |
| 2024-10-21 | (1) BlackRock, Inc. | 4.63M | 9.50% |
| 2024-04-29 | Bihua Chen | 2.5M | 5.15% |
| 2024-04-29 | Cormorant Global Healthcare GP, LLC | 2.5M | 5.15% |
| 2024-04-29 | Bihua Chen | 2.5M | 5.15% |
| 2024-04-29 | Cormorant Asset Management, LP | 2.5M | 5.15% |
| 2024-04-29 | Cormorant Global Healthcare Master Fund, LP | 2.5M | 5.15% |
| 2024-04-29 | Cormorant Global Healthcare GP, LLC | 2.5M | 5.15% |
| 2024-04-29 | Cormorant Global Healthcare Master Fund, LP | 2.5M | 5.15% |
| 2024-04-29 | Cormorant Asset Management, LP | 2.5M | 5.15% |
| 2023-06-12 | Robert Atchinson | 4M | 9.35% |
| 2023-06-12 | Phillip Gross | 4M | 9.35% |
| 2023-06-12 | Robert Atchinson | 4M | 9.35% |
| 2023-06-12 | Adage Capital Partners, L.P. | 4M | 9.35% |
| 2023-06-12 | Adage Capital Partners GP, L.L.C. | 4M | 9.35% |
| 2023-06-12 | Adage Capital Partners GP, L.L.C. | 4M | 9.35% |
| 2023-06-12 | Phillip Gross | 4M | 9.35% |
| 2023-06-12 | Adage Capital Advisors, L.L.C. | 4M | 9.35% |
| 2023-06-12 | Adage Capital Advisors, L.L.C. | 4M | 9.35% |
| 2023-06-12 | Adage Capital Partners, L.P. | 4M | 9.35% |
| 2023-06-05 | BVF I GP LLC | 3.02M | 6.80% |
| 2023-06-05 | BVF GP Holdings LLC | 4.23M | 9.60% |
| 2023-06-05 | Mark N. Lampert | 4.41M | 9.99% |
| 2023-06-05 | EcoR1 Capital Fund Qualified, L.P. | 4.64M | 11.00% |
| 2023-06-05 | Oleg Nodelman | 5M | 11.00% |
| 2023-06-05 | BVF Partners L.P. | 4.41M | 9.99% |
| 2023-06-05 | BVF Partners OS Ltd. | 140.58K | 1.00% |
| 2023-06-05 | BVF Inc. | 4.41M | 9.99% |
| 2023-06-05 | Oleg Nodelman | 5M | 11.00% |
| 2023-06-05 | EcoR1 Capital Fund Qualified, L.P. | 4.64M | 11.00% |
| 2023-06-05 | EcoR1 Capital, LLC | 5M | 11.00% |
| 2023-06-05 | BVF Partners L.P. | 4.41M | 9.99% |
| 2023-06-05 | Biotechnology Value Fund, L.P. | 3.02M | 6.80% |
| 2023-06-05 | BVF I GP LLC | 3.02M | 6.80% |
| 2023-06-05 | Biotechnology Value Trading Fund OS LP | 140.58K | 1.00% |
| 2023-06-05 | Biotechnology Value Fund, L.P. | 3.02M | 6.80% |
| 2023-06-05 | BVF II GP LLC | 1.21M | 2.80% |
| 2023-06-05 | Biotechnology Value Fund II, L.P. | 1.21M | 2.80% |
| 2023-06-05 | EcoR1 Capital, LLC | 5M | 11.00% |
| 2023-06-05 | Biotechnology Value Trading Fund OS LP | 140.58K | 1.00% |
| 2023-06-05 | BVF Partners OS Ltd. | 140.58K | 1.00% |
| 2023-06-05 | BVF GP Holdings LLC | 4.23M | 9.60% |
| 2023-06-05 | BVF Inc. | 4.41M | 9.99% |
| 2023-06-05 | Mark N. Lampert | 4.41M | 9.99% |
| 2023-06-05 | Biotechnology Value Fund II, L.P. | 1.21M | 2.80% |
| 2023-06-05 | BVF II GP LLC | 1.21M | 2.80% |
| 2023-06-02 | Lynx1 Capital Management LP | 5.22M | 12.20% |
| 2023-06-02 | Weston Nichols | 5.22M | 12.20% |
| 2023-06-02 | Lynx1 Capital Management LP | 5.22M | 12.20% |
| 2023-06-02 | Weston Nichols | 5.22M | 12.20% |
| 2022-09-30 | Parag Shah | 2.1M | 9.99% |
| 2022-09-30 | K2 HealthVentures Equity Trust LLC | 2.1M | 9.99% |
| 2022-09-30 | Anup Arora | 2.1M | 9.99% |
| 2022-09-30 | K2 HealthVentures Equity Trust LLC | 2.1M | 9.99% |
| 2022-09-30 | Parag Shah | 2.1M | 9.99% |
| 2022-09-30 | Anup Arora | 2.1M | 9.99% |
| 2022-08-15 | RA Capital Management, L.P. | - | 0.00% |
| 2022-08-15 | Peter Kolchinsky | - | 0.00% |
| 2022-08-15 | Rajeev Shah | - | 0.00% |
| 2022-08-15 | RA Capital Healthcare Fund, L.P. | - | 0.00% |
| 2022-02-14 | Pitango H.T. Fund I, L.P. | 1.08M | 4.60% |
| 2022-02-14 | Hillhouse Investment Management, Ltd. | 1.28M | 6.90% |
| 2022-02-14 | Pitango H.T. Fund I, L.P. | 1.08M | 4.60% |
| 2022-02-14 | Pitango HealthTech Fund I - Israel L.P. | 7498.0 | 0.03% |
| 2022-02-14 | Pitango HealthTech Fund I, L.P. | 1.05M | 4.40% |
| 2022-02-14 | Hillhouse Investment Management, Ltd. | 1.28M | 6.90% |
| 2022-02-14 | Pitango HealthTech Principals Fund I, L.P. | 22591.0 | 0.10% |
| 2022-02-14 | Deer IX & Co. Ltd. | 1.25M | 6.70% |
| 2022-02-14 | Deer IX & Co. L.P. | 1.25M | 6.70% |
| 2022-02-14 | Bessemer Venture Partners IX Institutional L.P. | 554K | 3.00% |
| 2022-02-14 | GV 2017, L.P. | 641.85K | 3.45% |
| 2022-02-14 | GV 2017 GP, L.L.C. | 641.85K | 3.45% |
| 2022-02-14 | Alphabet Holdings LLC | 1.08M | 5.78% |
| 2022-02-14 | GV 2017 GP, L.P. | 641.85K | 3.45% |
| 2022-02-14 | Alphabet Inc. | 1.08M | 5.78% |
| 2022-02-14 | GV 2019 GP, L.P. | 435.23K | 2.34% |
| 2022-02-14 | Pitango HealthTech Principals Fund I, L.P. | 22591.0 | 0.10% |
| 2022-02-14 | Pitango HealthTech Fund I - Israel L.P. | 7498.0 | 0.03% |
| 2022-02-14 | Pitango HealthTech Fund I, L.P. | 1.05M | 4.40% |
| 2022-02-14 | XXVI Holdings Inc. | 1.08M | 5.78% |
| 2022-02-14 | Deer IX & Co. Ltd. | 1.25M | 6.70% |
| 2022-02-14 | GV 2019, L.P. | 435.23K | 2.34% |
| 2022-02-14 | GV 2019 GP, L.L.C. | 435.23K | 2.34% |
| 2022-02-14 | Bessemer Venture Partners IX L.P. | 691.5K | 3.70% |
| 2022-02-14 | Bessemer Venture Partners IX L.P. | 691.5K | 3.70% |
| 2022-02-14 | Bessemer Venture Partners IX Institutional L.P. | 554K | 3.00% |
| 2022-02-14 | Deer IX & Co. L.P. | 1.25M | 6.70% |
| 2022-02-14 | GV 2019, L.P. | 435.23K | 2.34% |
| 2022-02-10 | Longwood Fund IV GP, LLC | 1.28M | 6.90% |
| 2022-02-10 | Longwood Fund IV GP, LLC | 1.28M | 6.90% |
| 2022-02-10 | Longwood Fund IV, L.P. | 1.28M | 6.90% |
| 2022-02-10 | Christoph H. Westphal | 2.32M | 12.40% |
| 2022-02-10 | Longwood Fund IV, L.P. | 1.28M | 6.90% |
| 2022-02-10 | Christoph H. Westphal | 2.32M | 12.40% |
| 2022-02-04 | (1)Names of reporting persons. BlackRock, Inc. | 1.5M | 8.00% |
| 2021-07-28 | RA Capital Management, L.P. | 1.26M | 6.70% |
| 2021-07-28 | RA Capital Healthcare Fund, L.P. | 1.1M | 5.90% |
| 2021-07-28 | Rajeev Shah | 1.26M | 6.70% |
| 2021-07-28 | Peter Kolchinsky | 1.26M | 6.70% |
| 2021-07-28 | Rajeev Shah | 1.26M | 6.70% |
| 2021-07-28 | Peter Kolchinsky | 1.26M | 6.70% |
| 2021-07-28 | RA Capital Healthcare Fund, L.P. | 1.1M | 5.90% |
| 2021-07-28 | RA Capital Management, L.P. | 1.26M | 6.70% |
| 2021-07-22 | Baker Bros. Advisors (GP) LLC | 1.42M | 7.60% |
| 2021-07-22 | Baker Bros. Advisors (GP) LLC | 1.42M | 7.60% |
| 2021-07-22 | Baker Bros. Advisors LP | 1.42M | 7.60% |
| 2021-07-22 | Julian C. Baker | 1.42M | 7.60% |
| 2021-07-22 | Julian C. Baker | 1.42M | 7.60% |
| 2021-07-22 | Baker Bros. Advisors LP | 1.42M | 7.60% |
| 2021-07-22 | Felix J. Baker | 1.42M | 7.60% |
| 2021-07-22 | Felix J. Baker | 1.42M | 7.60% |
TCRX Enterprise Value History
Annual
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2025-12-31 | $1.00 | 129.86M | $129.86M | $152.41M | $94.14M | $71.59M |
| 2024-12-31 | $3.04 | 111.99M | $340.45M | $178.69M | $97.38M | $259.14M |
| 2023-12-31 | $5.83 | 65.6M | $382.45M | $133.36M | $92.43M | $341.52M |
| 2022-12-31 | $1.55 | 24.05M | $37.27M | $120.03M | $85.98M | $3.23M |
| 2021-12-31 | $4.50 | 23.91M | $107.58M | $161.4M | $6.04M | -$47.78M |
| 2020-12-31 | $10.50 | 24.94M | $261.85M | $34.79M | $7.43M | $234.5M |
| 2019-12-31 | $10.50 | 24.94M | $261.85M | $41.76M | $4.89M | $224.98M |
Quarterly
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2026-06-30 | $0.98 | 129.95M | $127.36M | $100.16M | $69.82M | $97.03M |
| 2026-03-31 | $1.01 | 129.91M | $131.21M | $128.06M | $92.54M | $95.69M |
| 2025-12-31 | $1.00 | 129.86M | $129.86M | $152.41M | $94.14M | $71.59M |
| 2025-09-30 | $1.82 | 129.84M | $236.3M | $169.51M | $95.62M | $162.42M |
| 2025-06-30 | $1.45 | 129.73M | $188.11M | $169.39M | $96.7M | $115.42M |
| 2025-03-31 | $1.38 | 129.68M | $178.96M | $154.11M | $97.04M | $121.89M |
| 2024-12-31 | $3.04 | 120.79M | $367.2M | $178.69M | $97.38M | $285.89M |
| 2024-09-30 | $4.98 | 118.7M | $591.13M | $133.12M | $90.36M | $548.37M |
| 2024-06-30 | $5.93 | 113.43M | $672.61M | $242.16M | $94.69M | $525.14M |
| 2024-03-31 | $8.01 | 94.88M | $759.96M | $140.51M | $91.76M | $711.21M |
| 2023-12-31 | $5.83 | 94.84M | $552.89M | $133.36M | $92.43M | $511.97M |
| 2023-09-30 | $2.56 | 94.83M | $242.76M | $155.19M | $86.98M | $174.55M |